Investor Presentation: First Nine Months of 2020

76 Investor presentation First nine months of 2020 Growth momentum has increased driven by demographics and the Market Fit approach International Operations is diverse and covers 190 markets 14% 430M live with diabetes 12% 10% 570M live with obesity 8% 6% 4% IO's share of revenue 9M 2020 2% NAO 47% ΙΟ 53% NAO: North America Operations; IO: International Operations; SOG: Share of Growth Novo NordiskⓇ Historic growth has been in the range of 4-6% Growth momentum has benefitted from the Market Fit approach 12% 40% 30% mall 20% 10% 0% 2013 9M Aug Market Fit 2020 approach 2017 Growth rate range introduced NN Diabetes market share NN Diabetes SOG -Market growth NN Diabetes growth 30% 23% 13% 9% Aug 2020

View entire presentation